An approach to using recombinant erythropoietin for neuroprotection in very preterm infants.
about
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infantsEarly erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infantsErythropoietin for term and late preterm infants with hypoxic ischemic encephalopathyEarly erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infantsPharmacologic neuroprotective strategies in neonatal brain injuryErythropoietin and Neonatal NeuroprotectionMechanisms of cell-cell interaction in oligodendrogenesis and remyelination after strokeNeuroprotective potential of erythropoietin in neonates; design of a randomized trial.Outcomes of extremely low birth weight infants given early high-dose erythropoietin.Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?Increased fetal plasma and amniotic fluid erythropoietin concentrations: markers of intrauterine hypoxiaErythropoietin attenuates loss of potassium chloride co-transporters following prenatal brain injury.Postnatal erythropoietin treatment mitigates neural cell loss after systemic prenatal hypoxic-ischemic injuryThe Swiss Neonatal Quality Cycle, a monitor for clinical performance and tool for quality improvementNew antioxidant drugs for neonatal brain injury.The biological basis of injury and neuroprotection in the fetal and neonatal brain.Erythropoietin in stroke therapy: friend or foeThe role of cytokines and inflammatory cells in perinatal brain injury.Erythropoietin in brain development and beyond.Erythropoietin: still on the neuroprotection roadPostnatal Erythropoietin Mitigates Impaired Cerebral Cortical Development Following Subplate Loss from Prenatal Hypoxia-Ischemia.Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.Cord blood erythropoietin and interleukin-6 for prediction of intraventricular hemorrhage in the preterm neonatePerinatal brain damage: The term infant.Neonatal posthemorrhagic hydrocephalus from prematurity: pathophysiology and current treatment conceptsTherapeutic potential of erythropoietin and its structural or functional variants in the nervous system.Recombinant human erythropoietin improves neurological outcomes in very preterm infants.Erythropoietin for infants with hypoxic-ischemic encephalopathy.Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.Intranasal erythropoietin therapy in nervous system disorders.Neuroprotective role of erythropoietin in neonates.Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection.A meta-analysis of the protective effect of recombinant human erythropoietin (rhEPO) for neurodevelopment in preterm infants.Erythropoietin: a novel therapy for hypoxic-ischaemic encephalopathy?Urinary erythropoietin concentrations after early short-term infusion of high-dose recombinant epo for neuroprotection in preterm neonates.Placebo by Proxy in Neonatal Randomized Controlled Trials: Does It Matter?Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants.Erythropoietin Restores Long-Term Neurocognitive Function Involving Mechanisms of Neuronal Plasticity in a Model of Hyperoxia-Induced Preterm Brain Injury.Impaired ventilatory acclimatization to hypoxia in female mice overexpressing erythropoietin: unexpected deleterious effect of estradiol in carotid bodies.Erythropoiesis Stimulating Agents Demonstrate Safety and Show Promise as Neuroprotective Agents in Neonates.
P2860
Q24195000-47B4F87F-88AC-4382-91FC-0FE4B996255EQ24200642-E560FC62-42DB-44EC-8AED-1099F048FA3AQ24241152-27B7B4C1-3032-426C-A06A-1A214C19D73EQ24245418-2EA20C19-9361-4865-A011-A7CA94BDCDB4Q26852406-90D57EED-DAF4-408D-970C-D99C208DB070Q27009422-B6768C9D-8990-4A11-9ECB-5CACA0369FA6Q28083718-543D3948-EE81-403A-952D-A9AE07C0C037Q31071784-81A6C0DB-88DC-4310-82D0-50E9565179EEQ33642422-B68684E0-242B-42E5-BFD9-12E0FA5685DFQ33723452-68FF032E-8831-4A73-AFCA-A0F6FC5CE502Q33825380-E71C8231-554F-45CF-8EC1-96DD1355D558Q34053756-8AFEF4BE-9074-41C8-A446-B92D36687386Q34569855-851C261E-56CF-4C4E-A938-950766641816Q35001324-15B1E987-350B-4916-825C-4BC55204FB70Q35037632-EF7BCA18-6C33-42C6-9F48-9E49224347F5Q35201430-8708E8E7-B12F-4FBD-A3C2-6FD56AF10394Q35548966-AC014A15-050B-4826-8129-C008930657C4Q35864361-D52E6227-4084-4113-8529-CB03F77EBACCQ35909929-A10EDEDE-FBD0-4252-A08E-EC81F8AF2747Q35949322-67C8B96A-7331-4180-BC64-F2271BD2F77CQ35956626-F2488B5C-463B-4BA0-A0D4-E4E6525071F9Q36277628-605DE9E1-2C1E-4C4F-A92E-3B76F7C9161FQ36931953-99F53B2F-83DD-43D5-9B48-BDF1EE5AF048Q37025326-DE7DC95E-6454-4107-95D9-C7CF300C498AQ37347049-9CB146C1-31F9-4B98-AAC6-AF388E1BD8BDQ37358669-32B6E461-7271-4FEA-92EA-31CB0CE16B06Q37375616-961B7B54-7F27-4542-8200-8D56506F4A2CQ37678885-CE1AC697-CAE6-4606-9AEC-C293D86D0DE4Q37724782-C37D0229-0B91-431A-9335-A9A0060F073FQ37818329-6BACEA5F-8B6A-4AF4-8341-9835DA45C9D4Q38041616-657311AE-02B0-4417-8D29-2BAB0E65CA0FQ38255341-B2563BA1-5471-4598-A226-E0F38B71451DQ38258586-34002C07-A316-4085-B095-68F7441CCFB4Q38387887-F2ED2E84-7063-4516-91E5-1A3465D2FD3CQ39589208-9222CDA0-A101-4149-9B76-9CAF38421653Q41049306-8259523B-5C7F-4306-9F21-941948C894E5Q41656923-AFCB5E1C-789C-4CF5-9063-B7F6D814A56FQ41775024-054AF3FB-C4E8-4892-9879-7FF2E47696B4Q42879369-B469A380-1E19-4606-BAC3-C4A41BD4D812Q42949621-6AA17A5D-6A6A-4FD9-8452-7FB0EA541D98
P2860
An approach to using recombinant erythropoietin for neuroprotection in very preterm infants.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
An approach to using recombina ...... ction in very preterm infants.
@en
An approach to using recombina ...... ction in very preterm infants.
@nl
type
label
An approach to using recombina ...... ction in very preterm infants.
@en
An approach to using recombina ...... ction in very preterm infants.
@nl
prefLabel
An approach to using recombina ...... ction in very preterm infants.
@en
An approach to using recombina ...... ction in very preterm infants.
@nl
P2093
P356
P1433
P1476
An approach to using recombina ...... ction in very preterm infants.
@en
P2093
Brigitte Koller
Christof Dame
Hans Ulrich Bucher
Jean-Claude Fauchère
Martin Wolf
Reinhard Vonthein
Sandra Arri
P304
P356
10.1542/PEDS.2007-2591
P407
P577
2008-08-01T00:00:00Z